HoliStick Medical SAS, a new portfolio company of French VC firm Truffle Capital, has secured global exclusive rights to a novel tissue repair technology created by researchers at Harvard University, MIT, Boston Children's Hospital, and Brigham & Women's Hospital.
The licensed technology is a specialized catheter device for minimally invasive repair of holes in heart or tissue defects in...